Print

Print


Finding the Triggers for Parkinson’s Disease
Environmental engineer Kurt Pennell is investigating how pesticides and other 
common chemicals may linger in the brain and spur the illness on
By Marjorie Howard
Could common chemicals play a role in triggering Parkinson’s disease? It’s a 
distinct possibility, says Kurt Pennell, professor and chair of civil and 
environmental engineering.
Parkinson’s disease, a degenerative disorder of the central nervous system, 
results in resting tremors, stiffness and loss of movement. Efforts to identify 
its genetic cause have met with limited success, accounting for less than 10 
percent of the known Parkinson’s cases. That has led researchers to consider 
environmental culprits. Pennell suspects that that persistent organic 
pollutants, such as pesticides, insecticides and other chemicals that remain 
in the environment and linger in the body long after exposure, play a role in 
the onset and progression of Parkinson’s disease. 
 
“Our brains are particularly vulnerable because of their limited antioxidant 
capacity,” says Kurt Pennell. Photo: Joanie Tobin 
One of those chemicals is rotenone, a “natural” pesticide once widely used in 
organic farming, because it was believed to be safe. Instead, it has been 
shown in laboratory studies to induce Parkinson’s-like symptoms. Like other 
chemicals that Pennell studies, including PCBs and dieldrin, which was 
developed as an alternative to DDT, rotenone is hydrophobic, meaning it is not 
attracted to water and instead is drawn to fat, where it is stored. The human 
brain, which is two-thirds fat, is therefore a prime target for storing the 
chemical.
Scientists don’t think these chemicals directly cause Parkinson’s, a long-term 
disease that progresses very slowly. Rather, “having this exposure or having 
these chemicals in your system may increase the rate at which you start to 
have symptoms,” says Pennell. “So you may have them at a younger age or they 
may progress more rapidly.” 
Pennell says the presence of these compounds in the brain increases oxidative 
stress, a state in which the body is less able to fend off free radicals, which 
cause damage to the brain and to the body. Antioxidants are molecules that 
counteract the free radicals. 
“Our brains are particularly vulnerable because of their limited antioxidant 
capacity and potential for radical formation,” says Pennell. “We suspect that 
the presence of these compounds in the brain alters how dopamine is packaged 
and increases oxidative stress within neurons, meaning it could both 
predispose people to Parkinson’s and also accelerate the disease.” Dopamine is 
a chemical that acts as a neurotransmitter. In patients with Parkinson’s 
disease, dopamine-containing neurons located in the midbrain are damaged and 
eventually die, which reduces their ability to control movements. 
Pennell conducts his research in conjunction with the Collaborative Centers 
for Parkinson’s Disease Environmental Research at Emory University. “We expose 
animals to dieldrin, PCBs and other chemicals, and look at their response to 
that exposure,” he explains. “We look for markers of oxidative stress in the 
brain and for concentrations of chemicals in their tissue and in their blood. 
I measure the amount of chemicals and how long it persists in the body.” 
Pennell says the animals are given low concentrations of chemicals in an effort 
to mimic dose levels that might be found in the environment.
In the last decade scientists have begun to accept the idea that common 
chemicals can spur Parkinson’s along, says Pennell, but more studies, such as 
the ones he is conducting, are needed to prove it, and help understand 
relationships between chemical exposures, genetic predisposition and lifestyle 
factors in Parkinson’s disease. In addition, the ways in which oxidative 
stress contribute to nerve degeneration are not well understood. “We’d like to 
identify biomarkers that may indicate that someone is more susceptible to 
oxidative stress and eventually find therapies for people who have been exposed 
to these chemicals.” 
Tiny Particles, Big Questions
Pennell is also interested in finding out whether oxidative stress might be 
caused by nano materials, manufactured particles that are less than one 
millionth of a meter in size. Because they are so tiny, monitoring their use 
and disposal is challenging, and there are concerns they are escaping into the 
environment and may pose a health hazard.
Nanotechnology, which involves the use of these tiny particles, allows 
researchers to work on a molecular level. Nano-sized materials are 1/100 
nanometers in diameter. For scale, think about it this way: a sheet of paper 
is about 100,000 nanometers thick. 
The use of nano materials, says Pennell, has become increasingly common in 
products such as sunscreen and cosmetics and in medical applications such as 
imaging. And scientists predict nanotechnology will also be used in 
manufacturing, such as for aircraft, buildings and automobiles, taking 
advantage of its lightweight properties. In health care, nanotechnology is 
used when precision is key, such as delivering the right amount of medicine to 
the exact location in the body where it is needed most. 
But the consequences of using such tiny materials are unknown, since it is 
uncertain what effect they have on the environment and on the human body. There 
are concerns that nano materials could be discharged from industrial plants 
into waterways or accidentally released into the air during their production. 
Researchers are wondering if they may cause brain damage, resulting in such 
diseases as Parkinson’s.
Researchers need to understand how nano materials behave so they can learn how 
to better control them, says Pennell. In one project, he studies how carbon-
based nanoparticles move in water. He and Linda Abriola, dean of the school of 
engineering, recently received a $350,000 grant from the National Science 
Foundation to study the effects of metal-based nanoparticles on both the body 
and the environment. 
“No one really knows what happens if we release nanoparticles into the 
environment—what happens and where are they going to go,” says Pennell. “How 
will they be transported and retained? What happens if they reach a body of 
water or if they’re spilled or put into a dump? We need to understand how to 
control them.”

http://tuftsjournal.tufts.edu/2010/03_1/features/01/

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn